Megarobo key facts
as of Oct 2026- Developer and provider of collaborative robots focusing on automation of life science research.
- Megarobo is valued at approximately $1.3B as of Oct 2026 (last reported valuation).
- It has raised $580.3M; the latest was IPO in Jun 2025.
- Notable investors include CICC Capital, Innoangel Fund, Suzhou Guofa Venture Capital, Goldman Sachs Asset Management, Sinovation Ventures — 25 tracked in total.
- Status: In IPO Registration.
Megarobo's last reported valuation, Aug 2022. Nothing priced has surfaced since.
- ·The complete investor list: 25 names
- ·Watch Megarobo: the Monday email on marks, rounds and moves
Megarobo funding rounds
No funding rounds for Megarobo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Megarobo
25+Megarobo valuation
Megarobo's last reported valuation was $1.3 billion in Aug 2022. No priced round, secondary trade or fund mark has surfaced since.
Megarobo investors
25 investors are on record for Megarobo, including CICC Capital, Innoangel Fund, Suzhou Guofa Venture Capital and Goldman Sachs Asset Management.
About Megarobo
Developer and provider of collaborative robots focusing on automation of life science research. The company specializes in developing flexible, efficient and practical automation solutions for life science companies and scientific research institutions, providing innovative laboratory services that aim to increase research efficiency.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Employees
- 915
- Website
- megarobo.tech/
- Ownership
- In IPO Registration
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.